Belli Giulio, Fantini Corrado, D'Agostino Alberto, Belli Andrea, Langella Serena
Department of General and Hepato-Pancreato-Biliary Surgery, S.M. Loreto Nuovo Hospital, Via A. Vespucci, 80142, Naples, Italy.
J Hepatobiliary Pancreat Surg. 2005;12(6):488-93. doi: 10.1007/s00534-005-1006-z.
Laparoscopic surgery is a relatively new option for the treatment of hepatocellular carcinoma (HCC) on cirrhosis. To date, there have been only a few reports of this option for this pathology in the literature, probably because of the intra operative difficulties related to the treatment of this pathology (even at laparotomy) and because of the problems related to the minimally invasive approach (technical difficulties, complicated management of the bleeding, lack of dedicate tools, and fear of gas embolism). In this article we report four patients from our whole series (23 laparoscopic liver resections for HCC) who underwent a laparoscopic resection for completely exophytic HCC on cirrhosis, located in segment IV in two patients, and in segment III and segment V respectively, in the other two. The mean operative time was 116 min (range, 90-150 min). The Pringle maneuver was never performed. No blood transfusions were needed. No postoperative complications occurred, neither ascites, nor jaundice, nor encephalopathy. Postoperative liver function returned to the preoperative level within 3 days. Food intake started on postoperative day 2. The patients were discharged on postoperative days 5 (one patient), 6 (two patients), and 7 (one patient) after uncomplicated courses. In our opinion, limited laparoscopic liver resections could be considered, at present, to be the best option for the treatment of extremely rare protruding HCC on cirrhosis. We believe that a minimally invasive approach can minimize the postoperative morbidity rate, which is still too high in this group of patients. Our experience confirmed that nonanatomical limited resections or anatomical left lateral segmentectomies for HCC on cirrhosis are feasible and safe in the hands of surgeons trained in both open liver surgery and advanced laparoscopic surgery.
腹腔镜手术是治疗肝硬化合并肝细胞癌(HCC)的一种相对较新的选择。迄今为止,文献中关于这种病理情况采用该手术方式的报道仅有少数几例,可能是因为与这种病理情况的治疗相关的术中困难(即使是在开腹手术中),以及与微创方法相关的问题(技术困难、出血的复杂处理、缺乏专用工具以及对气体栓塞的担忧)。在本文中,我们报告了我们整个系列(23例腹腔镜肝切除术治疗HCC)中的4例患者,他们接受了腹腔镜切除术,用于治疗肝硬化上完全外生性的HCC,其中2例位于IV段,另外2例分别位于III段和V段。平均手术时间为116分钟(范围90 - 150分钟)。从未进行过Pringle手法。无需输血。未发生术后并发症,既没有腹水、黄疸,也没有脑病。术后肝功能在3天内恢复到术前水平。术后第2天开始进食。在经历无并发症的病程后,患者分别于术后第5天(1例患者)、第6天(2例患者)和第7天(1例患者)出院。我们认为,目前对于治疗肝硬化上极其罕见的突出型HCC,有限的腹腔镜肝切除术可被视为最佳选择。我们相信,微创方法可以将术后发病率降至最低,而在这类患者中,术后发病率仍然过高。我们的经验证实,对于肝硬化上的HCC,非解剖性有限切除术或解剖性左外侧段切除术在接受过开放肝手术和高级腹腔镜手术培训的外科医生手中是可行且安全的。